Showing results (81-90 of 90) with videos related to
Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
Infection and Immunity|January 31, 2007
Structural characterization of Campylobacter jejuni lipooligosaccharide outer cores associated with Guillain-Barre and Miller Fisher syndromesPeggy C R Godschalk, Mark L Kuijf, Jianjun Li, et al.Glycobiology|April 9, 2005
Novel biosynthetic functions of lipopolysaccharide rfaJ homologs from Helicobacter pyloriSusan M Logan, Eleonora Altman, Oksana Mykytczuk, et al.ACS Chemical Biology|March 20, 2020
Development and Characterization of Mouse Monoclonal Antibodies Specific for Clostridiodes (Clostridium) difficile Lipoteichoic AcidChantelle M Cairns, Henk van Faassen, Frank St Michael, et al.Antimicrobial Agents and Chemotherapy|September 22, 2010
Colistin resistance in Acinetobacter baumannii is mediated by complete loss of lipopolysaccharide productionJennifer H Moffatt, Marina Harper, Paul Harrison, et al.Proceedings of the National Academy of Sciences of the United States of America|June 5, 2013
Neisseria gonorrhoeae-derived heptose elicits an innate immune response and drives HIV-1 expressionRebecca J Malott, Bernd O Keller, Ryan G Gaudet, et al.Infection and Immunity|May 31, 2018
A Novel Sialylation Site on Neisseria gonorrhoeae Lipooligosaccharide Links Heptose II Lactose Expression with PathogenicitySanjay Ram, Sunita Gulati, Lisa A Lewis, et al.Molecular Microbiology|December 23, 2004
Analysis of Campylobacter jejuni capsular loci reveals multiple mechanisms for the generation of structural diversity and the ability to form complex heptosesAndrey V Karlyshev, Olivia L Champion, Carol Churcher, et al.Plos Pathogens|December 3, 2015
Utilizing CMP-Sialic Acid Analogs to Unravel Neisseria gonorrhoeae Lipooligosaccharide-Mediated Complement Resistance and Design Novel TherapeuticsSunita Gulati, Ian C Schoenhofen, Dennis M Whitfield, et al.Communications Medicine|April 11, 2025
Modifying the glycosylation profile of SARS-CoV-2 spike-based subunit vaccines alters focusing of the humoral immune response in a mouse modelTyler M Renner, Matthew Stuible, Martin A Rossotti, et al.Biotechnology and Bioengineering|March 29, 2023
A CHO stable pool production platform for rapid clinical development of trimeric SARS-CoV-2 spike subunit vaccine antigensSimon Joubert, Matthew Stuible, Simon Lord-Dufour, et al.Pageof 9